Skip to content

Aggregated n-of-1randomised controlled trial of nebulized fentanyl or nebulized furosemide in palliative care patients with refractory breathlessness

Aggregated n-of-1randomised controlled trial of nebulized fentanyl or nebulized furosemide in palliative care patients with refractory breathlessness

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210705003
Enrollment
19
Registered
2021-07-05
Start date
2019-01-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study aims to comparing the efficacy in relief breathlessness of nebulization with fentanyl, furosemide and sterile water by using N-of-1 study. An N-of-1 study is a within-patient randomized, double-blind, and crossover trials in each patient. Refractory breathlessness, Nebulized medications, N-of-1

Interventions

Study was done as 1 cycle of 3 day of treatment that done for nebulized fentanyl or furosemide or sterile water . Fentanyl 50 mcg or Furosemide 40 mg or sterile water that all diluted in sterile water
Fentanyl,Furosemide,Water

Sponsors

no
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria 1. Age more than 18 years 2. Breathlessness symptoms with scored more than 3 on mMRC. 3. Good orientation 4. Patients with refractory breathlessness Clarify by standard of care 5. Life expectancy more than 3 days, and clinical of breathlessness is stable

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1. Adverse reactions to Fentanyl or Furosemide 2. Medical use: Fentanyl, Furosemide 3. Confused, poor cognition or delirium 4. Resting respiratory rate between 8 and 20 per minute: Evaluate by Pulse Oximetry and Counting by observer

Design outcomes

Primary

MeasureTime frame
breathlessness intensity Borg scale 4 0-10

Secondary

MeasureTime frame
Visual cough score 4 0-10

Countries

Thailand

Contacts

Public ContactPhichai Chansriwong

Ramathiboi Hos Mahidol U

phichaionco103@gmail.com66819145448

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026